代谢调控与抗菌纳米平台 通过下调福氏芽胞杆菌感染下结肠癌中的糖酵解通路改善免疫抑制 疗法
Metabolic-Modulating and Antibacterial Nanoplatforms Improve Immunosuppression via Downregulating Glycolysis Pathway in Fusobacterium nucleatum-Infected Colorectal Cancer Therapy
Ma Jingwen, Zeng Yun, Wang Xiaoye, Liu Yuan, Xiao Dan, Zhou Bowei, Cai Na, Qiang Rong
Journal:ACS Applied Nano Materials
IF:5.8
DOI:10.1021/acsanm.6c02789
PMID:
Published:2026-08-27
research field:微生物电化学系统纳米材料环境工程生物电化学材料科学能量转换
Abstract
Fusobacterium nucleatum ( F.n. ) infection is closely related to poor prognosis and high mortality in colorectal cancer (CRC) patients, promotes the proliferation and migration of CRC cells, induces inflammation, and creates an immunosuppressive tumor microenvironment. Compared with CRC cells not infected with F.n. , F.n. -infected CRC cells exhibit greater glycolytic activity, considered as a beneficial metabolic change for establishing a symbiotic relationship between CRC cells and F.n. In this study, the classical glycolysis inhibitors 2-deoxy- d -glucose (2-DG) and tanshinone IIA (TAN IIA) were coloaded into zeolitic imidazolate framework-8 nanoparticles (DTZP NPs) to suppress F.n. -infected CRC growth. TAN IIA not only eliminated intratumoral F.n. but also acted as a chemotherapeutic drug against F.n. -infected CRC cells. DTZP NPs strongly inhibited both the F.n. -infected MC38 tumor model and the azoxymethane (AOM)/dextran sulfate sodium salt (DSS)-induced spontaneous CRC model by downregulating the NF-κB/HIF-1α/glycolysis pathway. DTZP NPs’ treatment improved the immunosuppressive tumor microenvironment, decreased the inflammatory levels in both serum and tumor tissue, and modulated the gut microbiota and its metabolites. In summary, we proposed combining anti-intratumoral F.n. with adjusting the tumor metabolism strategy, which could provide new insights into the treatment of F.n. -infected CRC in the future.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


